Clinical Trial Update: Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study

View source ↗

Summary

The PBS claims cohort study NCT02262702 sponsored by GlaxoSmithKline in osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Panadol Osteo (paracetamol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoarthritis | Status: WITHDRAWN